StonvexLoading…
StonvexStonvexStonvexCore line items from FOUR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.18B | $3.33B | $2.56B | $1.99B |
Operating Income | $351.00M | $247.00M | $115.00M | $94.70M |
Net Income | $119.00M | $230.00M | $86.00M | $75.10M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $8.71B | $5.04B | $3.39B | $2.55B |
Total Liabilities | $6.76B | $4.02B | $2.52B | $2.07B |
Cash & Equivalents | $964.00M | $1.21B | $455.00M | $702.50M |
Free Cash Flow OCF − CapEx | $624.00M | $493.00M | $332.00M | $267.40M |
Shares Outstanding | 1.33M | 1.67M | 1.94M | 3.86M |